On this page of StockholderLetter.com we present the latest annual shareholder letter from Candel Therapeutics, Inc. — ticker symbol CADL. Reading current and past CADL letters to shareholders can bring important insights into the investment thesis.
Candel Therapeutics, Inc. 2023 Annual Report to Securityholders
 • shareholder letter icon 5/30/2024 Letter Continued (Full PDF)
 • stockholder letter icon 5/23/2023 CADL Stockholder Letter
 • Benford's Law Stocks icon CADL Benford's Law Stock Score = 65


CADL Shareholder/Stockholder Letter Transcript:

Candel Therapeutics, Inc.
2023 Annual Report to Securityholders



shareholder letter icon 5/30/2024 Letter Continued (Full PDF)
 

CADL Stockholder/Shareholder Letter (Candel Therapeutics, Inc.) | www.StockholderLetter.com
Copyright © 2023 - 2025, All Rights Reserved

Nothing in StockholderLetter.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy.